Skip to main content
Italian Journal of Pediatrics logoLink to Italian Journal of Pediatrics
. 2025 Dec 23;52:12. doi: 10.1186/s13052-025-02172-8

3-M syndrome: evolution of the phenotype over time

Isabelle Bacchi 1,2,#, Sara Vandelli 1,3,4,#, Emanuele Coccia 1,2, Lucrezia Giannini 1,2, Roberta Zuntini 1, Rachele Teneggi 1, Stefano Giuseppe Caraffi 1, Maria Chiara Baroni 1,2, Gianluca Contrò 1, Adelaide Peruzzi 1,2, Irene Ambrosetti 1,5, Marzia Pollazzon 1, Chiara Sartori 6, Ekkehart Lausch 7, Uta Matysiak 8, Lucia Gambini 9, Giancarlo Gargano 10, Valeria Orlando 11, Antonio Novelli 11, Lorenzo Iughetti 3, Sheila Unger 12,13, Andrea Superti-Furga 12,13, Livia Garavelli 1,
PMCID: PMC12838503  PMID: 41437277

Abstract

Background

3-M syndrome is an autosomal recessive disease characterized by short stature, facial dysmorphism and skeletal anomalies. To date, biallelic pathogenic CUL7 variants are responsible for the majority of cases, but biallelic deleterious changes in OBSL1 and CCDC8 can also establish the diagnosis.

Cases presentation

We report two unrelated newborns showing clinical signs compatible with 3-M syndrome and we describe the evolution of the phenotype of the first patient over time. Molecular analysis identified two compound heterozygous CUL7 variants in the first individual and a homozygous CUL7 variant in the second one.

Conclusions

We reviewed the literature highlighting the clinical differences between patients with variants in CUL7, OBSL1 and CCDC8. Our paper highlights how the clinical diagnosis of 3-M is easier in the first months of life, while in older children the phenotype becomes increasingly nuanced. It also underlines the clinical relevance of Next Generation Sequencing and functional studies, which may be necessary to confirm the pathogenicity of some variants, becoming an essential part of the multidisciplinary management of patients.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13052-025-02172-8.

Keywords: 3 M syndrome, CUL7, OBSL1 and CCDC8

Background

3-M syndrome (OMIM# 273750, 612921, 614205) is a rare autosomal recessive disease characterized by severe pre- and post-natal growth retardation, bulbous nose, short thorax, prominent abdomen, slight slender tubular bones, tall vertebral bodies, and normal intelligence. It was first described in 1975 by Miller, McKusick and Malvaux, hence the name “3M” [1]. Biallelic pathogenic variants in the CUL7 gene, first described in 2005, are responsible for the majority of cases (OMIM #273750) [2]. Biallelic pathogenic variants in OBSL1 (OMIM #612921) and CCDC8 (OMIM #614205), identified in 2009 and 2011 respectively [3, 4], can also establish the diagnosis. More than 200 patients with molecular confirmation have been described to date [241].

CUL7 encodes a protein called cullin 7, involved in the E3 ubiquitin-protein ligase complex [42]. E3 ubiquitin ligases catalyze the ubiquitination process, i.e. the binding of ubiquitin proteins to specific protein substrates, that are subsequently targeted for degradation and recycling via the proteasome complex [2, 6, 43]. E3 ligases are crucial in physiological bone growth and bone metabolism [44]. The vast majority of pathogenic and likely pathogenic variants are frameshift and nonsense variants, followed by splice site and missense variants. Small deletions are prevalent over small duplications.

OBSL1 codes for the obscurin-like protein 1, a cytoskeletal adaptor and a regulator of the Cul7-RING (FBXW8) ubiquitin-protein ligase. Deleterious variants in the OBSL1 gene are mainly frameshift and nonsense variants, but rare splice site and missense variants have also been reported in the literature. Small duplications are slightly more represented than deletions [3, 8].

CCDC8 encodes the coiled-coil domain containing protein 8, a cofactor required for p53-mediated apoptosis following DNA damage. It does not interact directly with cullin 7, but coimmunoprecipitation studies indicate a physical interaction with obscurin-like protein 1 [44]. To our knowledge, deleterious variants identified in CCDC8 are usually missense, while duplications and delins are very rare [11, 42].

Here we review and re-evaluate a comprehensive selection of clinical information from all the individuals affected by 3 M syndrome described in the literature to date. Moreover, we present two novel cases with biallelic variants in the CUL7 gene, and we describe their clinical features typical of 3 M syndrome over time.

Methods

Genetic analysis

Patient 1

DNA was extracted from peripheral blood samples of the proband and his parents.

Single nucleotide polymorphism array (SNP-array) was performed using Illumina CytoSNP-850 K with an average coverage of 100Kb and an average spacing of 5Kb-1Kb in the relevant gene regions, following the guidelines of the International Collaboration for Clinical Genomics (ICCG) and the Cancer Cycogenomics Microarray Consortium (CCMC).

-Trio Whole Exome Sequencing (WES) analysis was performed using ClinEX pro kit (4bases) on Illumina NovaSeq6000 platform. Only coding regions and exon-intron junctions (± 5 bp) of genes associated with skeletal dysplasias where studied. Analytical sensitivity and specificity were higher than 99%. The average coverage of the aligned regions was 278.63X. Only regions with a minimum read depth of 30x were considered for interpretation.

For transcript analysis, total RNA was isolated from peripheral blood mononuclear cells, using RNeasy Mini Kit (Qiagen). A total of 1 µg RNA was reverse-transcribed into cDNA using Oligo-dT and Random Hexamer primers using Transcriptor First Strand cDNA synthesis kit (Roche). PCR for the evaluation of splicing alteration was performed with specific forward primers (TCAACTGCCATGTCTACAAG) and specific reverse primers (ATTCAGCACCACGGCATAG) under standard condition. PCR products were analyzed by standard gel electrophoresis and sequenced on an ABI 3500 Genetic Analyzer (Thermo Fisher Scientific). β-actin was used as internal control.

All the variants were annotated using NCBI transcripts (GRCh38), and classified according to the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) recommendations [45, 46].

Patient 2

DNA was extracted from peripheral blood samples of the proband and his parents.

Whole exome sequencing (WES) was performed using the Ion AmpliSeq™ Exome RDY Kit on the Ion Torrent S5 Sequencer, AmpliSeq Exome Hi-Q analysis workflow (Germline) − 540 - w1.2 – Single Sample r.0. The non-coding intronic regions that are analyzed for genes extend for approximately 20 nucleotides upstream and downstream of each exon. The sequences are aligned to the Genome Reference Consortium Human Build 37 (GRCh37) reference genome. Confirmatory analysis of pathogenic (C5), likely pathogenic (C4) or of uncertain clinical significance (C3) variants was performed by Automated Direct Sequencing on the 3500 Dx.

Genetic Analyzer (Thermo Fisher Scientific). Average coverage of sequenced regions 100X.

Review of the literature

The aim of this review was to analyze the state of the art of the clinical phenotype of patients with 3-M Syndrome. We searched MEDLINE (PubMed) with the keywords ”3 M syndrome”, ”3- M syndrome”, “THREE M syndrome” and using the filter “Human”, limited to articles written in English and published up to March 2025 to ensure optimal data collection. In order to standardize our analysis, we excluded cases without a molecular diagnosis and reports with insufficient clinical information. Only post-natal cases were included.

We retrieved 36 publications, from 1975 to March 2025, describing a total of 217 individuals with genetic confirmation of 3-M syndrome; 177 of these included X-ray imaging data.

We collected information about gender and age, anthropometric parameters at birth and at the specified evaluation, clinical and radiological features, neurodevelopment, and genetic characteristics. The collected information from each article is shown in Supplementary Tables 13. Not all the features were assessed in all patients. Some case reports in the literature are more detailed than others, so we summarized the available data evaluated by the different authors. Where photographs of patients were available, we inferred some missing information from the photographs.

Statistical analysis

Given the limited number of samples and qualitative nature of clinical feature assessment, statistical analysis was mainly descriptive. The proportion of each variant in the male and female population was assessed using a binomial test, with a confidence interval (CI) of 95%. The Comparisons between frequencies were performed using Chi-square test or Fisher’s exact test as appropriate, depending on sample size, with a CI of 95%.

Clinical report

Patient 1

First evaluation at 6 months

The first male patient initially came to our attention at the age of 6 months. The family history revealed a maternal lineage predisposition to short stature. At birth, length was 41 cm (< 1st centile, -3.42 SD), weight was 2,010 g (1st centile, -2.48 SD) and head circumference was 33 cm (10th centile, -1.27 SD). At the age of 6 months, the child had a length of 58 cm (< 1st centile, -3.70 SD) and a weight of 5,250 g (< 1st centile − 3.14 SD). The head circumference was 43.5 cm (45th centile, -0.12 SD). Pubertal stages were A0P1B1. Psychomotor development was appropriate for the age.

At the physical examination, the patient exhibited relative macrocephaly, dolichocephaly, and frontal bossing. He had short neck with prominent trapezius muscles, squared off shoulders, winged scapulae, pectus excavatum, short and broad thorax, hyperlordosis, protuberant abdomen with diastasis recti, short limbs and prominent calcaneus. He showed hypotonia and joint laxity. The main facial features included triangular face, hypoplastic midface, full eyebrows, bulbous nose, long philtrum, pointed chin, protruding ears – overall, the face gave the impression of a melancholic aspect (Fig. 1A-E).

Fig. 1.

Fig. 1

Phenotype of patient 1 at the age of 6 months, 2 years and 12 years. Phenotype at the age of 6 months: relative macrocephaly, dolichocephaly, short neck, squared off shoulders, pectus excavatum, short and broad thorax, protuberant abdomen with diastasis recti, short limbs and prominent calcaneus. Main facial features: triangular face, frontal bossing, hypoplastic midface, full eyebrows, bulbous nose, long philtrum, pointed chin, protruding ears with the impression of a melancholic aspect of the face. (A-E). Phenotype at the age of 2 years: squared off shoulders, protuberant abdomen and prominent calcaneus. Main facial features: triangular face, thick eyebrows, bulbous nose, long philtrum, pointed chin (F-J). Phenotype at the age of 12 years: Rather short thorax, slightly protuberant abdomen with diastasis recti. Main facial features: slightly depressed nasal bridge, bulbous nasal tip pointing upwards, slightly pointed chin, bilateral brachydactyly (K-P)

X-ray showed slender and elongated long bones, with diaphyseal constriction and cortical thickening (Fig. 2C); the vertebrae appeared tall with reduced anteroposterior diameter (Fig. 2A, B); the bones of both hands were thin (Fig. 2E).

Fig. 2.

Fig. 2

Radiographs of patients 1 and 2. X-rays of patient 1 at birth: slender and elongated long bones, with diaphyseal constriction and cortical thickening (C); tall vertebrae, with reduced anteroposterior diameter (A, B); thin metacarpals and phalanges (E). Left wrist and hand X-ray of patient 1 at the age of 2 years: Skeletal maturation assessment on X-rays of the left wrist and hand with the Greulich and Pyle method: marked delay, with bone age of 9 months at the chronological age of 2 years (F). X-rays of patient 1 at the age of 12 years: delayed skeletal maturation, with a bone age of 9–10 years. Slightly tall lumbar vertebral bodies, thin long bones (G-K). X-rays of patient 2 at birth: slightly slender bones and lightly flared metaphyses of the distal femur and proximal tibia without other evident signs of skeletal dysplasias (L-O)

Evaluation at 2 years

The child was next evaluated at the age of two years. His height was 77 cm (< 1st centile, -2.92 SD), weight was 8,150 g (< 1st centile, -3.71 SD), and head circumference was 50 cm (83rd centile, + 0.96 SD). Pubertal stages were A0P1B1, and testicular volume was 1 cc bilaterally. On physical examination, his shoulders appeared squared off, the protuberant abdomen and prominent calcaneus were still evident. The main facial features were unchanged: triangular face, thick eyebrows, bulbous nose, long philtrum, pointed chin (Fig. 1F-J).

Skeletal maturation assessment on X-rays of the left wrist and hand with the Greulich and Pyle method showed a marked delay, with bone age of 9 months at the chronological age of 2 years (Fig. 2F).

Evaluation at 12 years

The patient was unavailable to follow-up for about 10 years, until he was referred for genetic counseling again because of concerns about poor growth. At the age of 12 years, his biometric parameters were: height 136.3 cm (4th centile, -1.76 SD), weight 42.5 Kg (57th centile, + 0.17 SD) and head circumference 55.5 cm (88th centile, + 1.19 SD). Puberal stages were A + P3B1 and testicular volume was 5 cc bilaterally. Seated height was 73.5 cm (3rd centile), span 139 cm, and seated height/height ratio 0.54 (+ 2.5 SD). He was well below his genetic target of 179.5 cm. On physical examination, he had slightly depressed nasal bridge, bulbous nasal tip pointing upwards, slightly pointed chin, bilateral brachydactyly, and single transverse palmar crease on the right hand. The thorax was rather short, but the hint of pectus excavatum that was present as a child was no longer evident. The examination showed a slightly protuberant abdomen with diastasis recti. Heels were no longer prominent. Bilateral flat foot was noticed as well as joint laxity, especially distal. Phenotype was otherwise normal, with regular body proportions (Fig. 1K-P).

The radiological evaluation showed delayed skeletal maturation, with a bone age of 9–10 years. The lumbar vertebral bodies appeared slightly tall and the long bones appeared thin (Fig. 2G-K).

Genetic testing

Chromosomal microarray analysis, by way of SNP-array analysis, identified no copy number variants or Loss of Heterozygosity regions.

WES performed on the proband-parents trio and filtered for genes associated with skeletal dysplasias revealed two compound heterozygous variants in the CUL7 gene (NM_014780.5): a missense variant inherited from his mother, c.4391 A > C p.(His1464Pro), already reported in the literature and classified as likely pathogenic (Huber_2005, Li_2014, Yan_2014), and an intronic variant of uncertain significance (VUS) inherited from his father, c.2063 + 5G > C p.(?).

This VUS is extremely rare in population databases (gnomAD v4.1.0, accessed on 18/04/2025) and in silico predictions (SpliceAI) suggest a possible effect on splicing. Transcript analysis on mRNA from the patient’s peripheral blood performed to assess the causative role of the c.2063 + 5G > C variant showed that it is responsible for skipping of exon 8, causing the formation of a premature stop codon, p.Ala609Serfs*3 (Fig. 3). This functional study allowed us to reclassify the variant as likely pathogenic and confirmed the diagnosis of 3 M syndrome.

Fig. 3.

Fig. 3

Functional analysis. Transcript analysis on mRNA from the patient’s peripheral blood performed to assess the causative role of the c.2063 + 5G > C variant showed that it is responsible for skipping of exon 8, causing the formation of a premature stop codon, p.Ala609Serfs*3

Patient 2

Evaluation at 4 months

The second male patient came to us for evaluation at the age of 4 months. The parents were first cousins and the child had three healthy siblings. During pregnancy, ultrasound indicated the possibility of a skeletal dysplasia, but the mother was unwilling to undergo prenatal invasive investigations. The child was born at 40th week of gestation with a birth weight of 2,200 g (1st centile, -2.18 SD), length of 41 cm (< 1st centile, -3.42 SD) and head circumference of 34 cm (20th centile, -0.83 SD). Apgar score was 9 at 1 and 5 min. The patient was admitted to the Neonatal Department where high-flow oxygen therapy was administered for 2 days. During hospitalization a right inguinal hernia was diagnosed. The babygram x-rays showed slightly slender bones and lightly flared metaphyses of the distal femur and proximal tibia without other evident signs of skeletal dysplasias (Fig. 2L-O). Transfontanellar ultrasound, brain MRI, echocardiography, auditory evoked potentials and abdominal ultrasound were all normal. At the age of 4 months, he presented the following measurements: length 52 cm (< 1st centile, -4.75 SD), weight 3,950 g (< 1st centile, -3.59 SD), head circumference 40 cm (7th centile, -1.46 SD); his genetic target for height was 175.5 cm. Pubertal stages were A0P1B1 and testicular volume was 1–2 ml bilaterally. He had relative macrocephaly, a high and rounded forehead, a slight frontal bossing, depressed nasal bridge, bulbous nasal tip, very short thorax, very protuberant abdomen (Fig. 4A-C), brachydactyly of both hands (Fig. 4D-E), prominent calcaneus (Fig. 4J-K), mild hypotonia, no limitation of elbow extension.

Fig. 4.

Fig. 4

Phenotype of patient 2 at the age of 4 months and 9 months. Phenotype at the age of 4 months: relative macrocephaly, very short thorax, very protuberant abdomen. Main facial features: high and rounded forehead, slight frontal bossing, depressed nasal bridge, bulbous nasal tip, (A-C), brachydactyly, (D-F), prominent calcaneus (G). Phenotype at the age of 9 months: relative macrocephaly, short thorax, protuberant abdomen. Main facial features: high forehead, slight frontal bossing, depressed nasal bridge, bulbous nasal tip, (H-1, N) prominent calcaneus (J-M)

Evaluation at 9 months

At the last evaluation at the age of 9 months his auxological parameters were: length 57 cm ( < < 3rd centile, -5.37 SD), weight 4,940 g ( < < 3rd centile, -4.48 SD), head circumference 43 cm (4th centile, -1.74 SD) Pubertal Stages were A0P1B1 with testicular volume 1–2 ml and mobile right testicle. He still had right a inguinal hernia (Fig. 4F-I; L-N).

Genetic testing

WES analysis showed the deletion of six nucleotides in CUL7, the last four of intron 4 and the first two of exon 5, c.1234-4_1235del in the homozygous state inherited from both parents. This alteration causes the loss of the canonical slicing acceptor site and a portion of exon 5 leading to an alteration of the transcript and consequently of the synthesis of the protein. The variant is not present in gnomAD v.4.1.0 (accessed on 18/04/2025) and was classified as likely pathogenic.

Discussion

When faced with a newborn or infant with a frankly pathological length as in our two cases, it is natural for the neonatologist and the pediatrician to think of a skeletal dysplasia and request a radiological examination such as an antero-posterior and latero-lateral babygram. In the case of 3-M syndrome, it is surprising how the radiological evaluation can often detect signs that are too vague to clearly orient the diagnostic process. If a precise suspicion has not already been formulated by the neonatologist, the pediatrician or the clinical geneticist, these signs can easily be overlooked. For this reason, it is of fundamental importance to define the most significant clinical and radiological signs in newborns and infants.

In reviewing the literature, we retrieved 217 cases of 3-M syndrome with molecular diagnosis fitting the inclusion criteria: 135 with CUL7, 70 with OBSL1, and 12 with CCDC8 variants. Among cases with variants in the CUL7 gene, about one third (43/135) belong to a population isolated with high genetic homogeneity, the Yakuts, described by Maksimova et al. in 2007 [5]. 3-M syndrome cases from Yakut families share the same pathogenic variant, NM_014780.5:c.4581dup (also reported as c.4582insT in previous works), and were noted to have some distinctive features, in particular a lower occurrence of radiological findings. We propose that including the Yakut population may lead to a bias in the generalized clinical comparison of CUL7-related 3-M syndrome patients, given that the remaining cases are 92 individuals from 62 independent families, encompassing 62 different variants. For these reasons, in our review we considered the Yakut population separately, and we excluded them while calculating the total frequency of each clinical feature. Indeed, comparing 3-M syndrome cases in the Yakut population with all other CUL7-related cases, we confirmed that the radiological findings are significantly less frequent in the Yakuts (Supplementary Table 5): these include slender long bones (79% vs. 2%, P = 2.2E-08), tall vertebral bodies (63% vs. 9%, P = 6.6E-05) and flared metaphyses (91% vs. 26%, P = 0.003). Another significant difference concerns clinodactyly (62% vs. 9%, P = 7.7E-05), while all other aspects of 3 M syndrome are comparable between the two groups. For ease of reference with previous articles [41], in the Supplementary Materials we also provide the frequencies of each feature including the Yakut population (Supplementary Table 6). As expected, in this total the prevalence of the radiological features is markedly lower. This may lead to underestimating the central role of radiological evaluation in the differential diagnosis of 3 M syndrome from other short stature syndromes.

In the supplementary materials, we provide tables schematizing the clinical features and variants collected (CUL7: Supplementary Tables 1 and 6, OBSL1: Supplementary Table 2, CCDC8: Supplementary Table 3). A comparison of the prevalence of the clinical characteristics of 3 M syndrome patients, divided according to the gene involved, is provided in Table 1 and Supplementary Table 4.

Table 1.

Comparison of phenotypic characteristics in patients with variants in CUL7, OBSL1 and CCDC8

Individual with CUL7 diagnosis Individual with OBSL1 diagnosis Individual with CCDC8 diagnosis

N

(n per gender)

92

(34 F/58 M)

53%

70

(34 F/36 M)

40%

12

(6 F/6 M)

7%
Birth weight in SD

-3.02 ± 1.03

(-2.90)

-2.69 ± 0.81

(-2.71)

-3.43 ± 1.52

(-3.05)

Parameters at first reporting
Age in years 6.04 ± 6.81 (3.00) 7.05 ± 9.37 (4.50) 4.27 ± 4.00 (3.40)
Weight in SD

-3.78 ± 1.73

(-4.0)

-3.26 ± 1.80

(-3.39)

-3.65 ± 1.23

(-3.9)

Height in SD

-5.32 ± 1.32

(-5.20)

-4.49 ± 1.45

(-4.60)

-4.34 ± 1.64

(-3.5)

Head circumference in SD

-0.75 ± 1.32

(-0.77)

-0.75 ± 1.55

(-0.81)

-1.56 ± 1.13

(-1.0)

Facial features
Dolichocephaly 50/79 63% 39/58 67% 3/12 25%
Triangular face 82/89 92% 54/62 87% 6/12 50%
Frontal bossing 76/90 84% 46/59 78% 11/12 92%
Hypoplastic midface 73/82 89% 41/59 69% 6/12 50%
Bulbous nose 84/90 93% 56/62 90% 8/12 67%
Anteverted nares 58/63 92% 35/44 80% 8/12 67%
Long philtrum 77/83 93% 47/58 81% 4/10 40%
Full lips 72/85 85% 45/60 75% 6/12 50%
Pointed chin 75/84 89% 50/62 81% 7/10 70%
Prominent ears 35/53 66% 23/37 62% 5/9 56%
Midline facial haemangioma 11/37 30% 6/32 19% 2/5 40%
Lower eyelid fat pads 18/54 33% 13/41 32% 0/6 0%
Thick eyebrows 50/67 75% 36/45 80% 4/6 67%
Prominent central tubercle of upper lip 21/37 57% 17/23 74% 2/5 40%
Other features
Short neck 76/84 90% 45/58 78% 6/10 60%
Short thorax 68/72 94% 42/50 84% 7/8 88%
Pectus deformity 36/66 55% 28/53 53% 2/10 20%
Squared-off shoulders 28/35 80% 16/23 70% 3/7 43%
Winged scapulae 8/18 44% 2/12 17% 0/7 0%
Chest groove 14/27 52% 12/25 48% 2/7 29%
Protuberant abdomen 30/35 86% 22/27 81% 0/1 NA
Spine
Hyperlordosis 52/72 72% 36/51 71% 7/12 58%
Scoliosis 11/62 18% 13/48 27% 2/12 17%
Extremities
Hip dislocation 12/62 19% 1/29 3% 2/10 20%
Joint hypermobility 42/59 71% 22/47 47% 4/12 33%
Clinodactyly 47/76 62% 32/55 58% 3/12 25%
Unique transverse palmar crease 14/22 64% 2/9 22% 0/0 NA
Pes planus 49/56 88% 31/39 79% 0/1 NA
Spina bifida occulta 8/36 22% 1/25 4% 1/11 9%
Prominent heels 73/81 90% 40/50 80% 9/12 75%
Radiological features
Slender long bones 57/72 79% 41/51 80% 7/11 64%
Tall vertebral bodies 45/71 63% 33/50 66% 5/11 45%
Flared metaphyses 30/33 91% 17/23 74% 1/1 NA
Diaphyseal constriction 37/43 86% 24/28 86% 1/1 NA
Neurodevelopment
Psychomotor delay 8/45 18% 5/25 20% 1/5 20%
Normal Intellect 39/39 100% 20/22 91% 5/5 100%

In the table some clinical features are derived from pictures of articles. List of clinical features was adapted from Hanson et al., 2009 and Lugli et al., 2016. Birth weight, age, height and weight at the presentation are reported as mean ± standard deviation (median). F, female; M, male; SD, standard deviation; NA: not available; 0/0 if this characteristic has not been assessed in that patient and cannot be deduced from the photographic images

Variants in CUL7 were reported more frequently in males (63%, p value 0.016), while variants in OBLS1 and CCDC8 have almost overlapping frequency in males and females. The mean age at reporting was higher in OBSL1 patients (7.05 ± 9.37 years) than in CUL7 (6.04 ± 6.81 years) or CCDC8 patients (4.27 ± 4.00 years). Nearly all patients displayed short stature at the time of first reporting, with average height slightly lower in CUL7 patients (Table 1). Interestingly, only two patients with OBSL1-related 3 M syndrome had normal height [24, 37], while all others had borderline (3rd centile, -1.9 SD) to severe short stature (< 1st centile, up to -9.3 SD).). On average, the head circumference at the presentation was in the low range of normal in CCDC8 patients (-1.56 ± 1.13 SDS), whereas it was close to normal in the other patients, with a few outliers.

Overall, when considering the phenotype of 3 M syndrome as a whole, we often think of the CUL7-related phenotype, because of the earlier identification and the greater number of cases.

Based on the observations in our patients (Figs. 1A, B, C, D and E and 4A, B, C, J and K) and from the review of the literature, including an accurate re-examination of photographs from published cases, we propose that the main features for guiding clinical suspicion, already evident in the neonatal period, are short length/short stature, short thorax, protuberant abdomen, prominent heels, and a characteristic appearance of the nose, with a bulbous or fleshy nasal tip, anteverted nares and often a depressed, concave bridge. These features are well represented in all three gene-related categories, although for CCDC8 it should be noted that the number of patients reported to date is very small and comparisons are not currently reliable. We also highlight the mild radiological signs (Fig. 2) such as slender long bones, tall vertebral bodies and flared metaphyses, which must be carefully evaluated together with radiologists expert in skeletal dysplasias, because they are very mild, but significant nonetheless, as it is our task to establish a differential diagnosis between the various and numerous skeletal dysplasias. In the two novel patients described here, all these characteristic clinical features of 3-M syndrome were present from the first months of life, and guided the genetic investigations.

At later ages, it is much more difficult to suspect 3-M syndrome because the radiological signs are always vague and the clinical signs are less and less evident: in addition to the short stature, there remains a slightly protuberant abdomen that may be overlooked by the clinician because it looks like a common anatomical variant, and the characteristic appearance of the nose. The latter must be taken into consideration because it is truly particular and typical of this condition.

Due to their relevance in the follow-up care, it is also important to consider the skeletal features, such as pectus deformity, winged scapulae, hyperlordosis, scoliosis, hip dislocation, joint hypermobility, pes planus and spina bifida occulta. Scoliosis is more frequent in patients with variants in OBSL1 (27% of cases, compared with 18% of patients with variants in CUL7 and 17% of patients with variants in CCD8), while all the others are slightly more represented in patients with variants in CUL7. It is therefore important in these patients to have a follow-up care with periodic pediatric orthopedic and physiatric check-ups.

About 20% of the patients, evenly distributed among the three variants, showed psychomotor development delay, despite normal intelligence in adulthood. It should be noted that only patients with variants in OBSL1 presented with intellectual disability, while the majority of patients with CUL7- or CCDC8-related 3-M syndrome and available neuropsychological assessment data had normal intellect. OBSL1 is known to play an important role in the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in the brain [47].

Conclusions

The diagnosis of 3-M syndrome is usually quite evident in the first months of life, while it can be much more difficult at later ages. In particular, in a newborn, in the presence of reduced length, the most important clinical features are the bulbous tip of the nose, the short thorax, the protuberant abdomen and the prominent calcaneus. Radiological signs are generally very vague in the newborn, but a careful evaluation can highlight the presence of thin long bones, flared metaphyses and slightly tall vertebral bodies. The phenotype becomes much more nuanced in the older child, but the appearance of the nose remains characteristic, and the abdomen remains slightly protuberant. In our study, we analyzed the genotype-phenotype correlation through a literature review that examined phenotypic differences among patients with variants in the three genes associated with 3-M syndrome. Our findings broadened the phenotypic and genotypic spectrum and highlighted the importance of early diagnosis and planned follow-up care, starting in the neonatal period. Accurate phenotyping is extremely important for the diagnostic process: when clinical evaluation is strongly indicative of a specific condition, it can guide diagnostic investigations, and may justify the effort of performing functional studies to confirm the pathogenicity of a variant of uncertain significance.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (75.3KB, xlsx)

Acknowledgements

This work has been generated within the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA) [EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516]. We also thank all cooperating family members for contributing the medical data necessary for this study. In addition, we are grateful to Luca Valcavi for helping with the design and adaptation of the figures.

Abbreviations

ACMG

American College of Medical Genetics

AMP

Association for Molecular Pathology

NGS

Next generation sequencing

OFC

Occipitofrontal circumference

SD

Standard deviation

WG

Weeks of gestation

Author contributions

IB, SV and LG conceptualized the report. RZ, EL, UM, and VO performed the molecular tests. EC, GC, MP, CS, RT, MCB, LuG, AP, IA collected clinical and genetical data. IB and SV drafted the first version of the paper. LG, AN, LI, GG, SU and ASF revised the manuscript. ASF revised the paper and gave final approval of the version to be submitted. All authors approved the final manuscript as submitted.

Funding

No funding was granted for this research.

Data availability

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

Written informed consent was obtained from parents at admission of their children. The study was approved by the Mother and Child Department of the AUSL IRCCS Reggio Emilia, Italy. All procedures performed in this report were in accordance with the ethical standards of the institutional and national research committee, and with the 1964 Helsinki declaration and its later amendments, or comparable ethical standards.

Consent for publication

Written informed consent for publication was obtained.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Isabelle Bacchi and Sara Vandelli contributed equally to this work.

References

  • 1.Miller JD, McKusick VA, Malvaux P, Temtamy S, Salinas C. The 3-M syndrome: a heritable low birthweight dwarfism. Birth Defects Orig Artic Ser. 1975;11(5):39–47. [PubMed] [Google Scholar]
  • 2.Huber C, Dias-Santagata D, Glaser A, O’Sullivan J, Brauner R, Wu K, Xu X, Pearce K, Wang R, Uzielli ML, Dagoneau N, Chemaitilly W, Superti-Furga A, Dos Santos H, Mégarbané A, Morin G, Gillessen-Kaesbach G, Hennekam R, Van der Burgt I, Black GC, Clayton PE, Read A, Le Merrer M, Scambler PJ, Munnich A, Pan ZQ, Winter R, Cormier-Daire V. Identification of mutations in CUL7 in 3-M syndrome. Nat Genet. 2005;37(10):1119–24. [DOI] [PubMed] [Google Scholar]
  • 3.Hanson D, Murray PG, Sud A, Temtamy SA, Aglan M, Superti-Furga A, Holder SE, Urquhart J, Hilton E, Manson FD, Scambler P, Black GC, Clayton PE. The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1. Am J Hum Genet. 2009;84(6):801–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hanson D, Murray PG, O’Sullivan J, Urquhart J, Daly S, Bhaskar SS, Biesecker LG, Skae M, Smith C, Cole T, Kirk J, Chandler K, Kingston H, Donnai D, Clayton PE, Black GC. Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth. Am J Hum Genet. 2011;89(1):148–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Maksimova N, Hara K, Miyashia A, et al. Clinical, molecular and histopathological features of short stature syndrome with novel CUL7 mutation in yakuts: new population isolate in Asia. J Med Genet. 2007;44(12):772–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Huber C, Delezoide A-L, Guimiot F, Baumann C, Malan V, Le Merrer M, et al. A large- scale mutation search reveals genetic heterogeneity in 3 M syndrome. Eur J Hum Genet. 2009;17:395–400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hanson D, Murray PG, Black GC, Clayton PE. The genetics of 3-M syndrome: unravelling a potential new regulatory growth pathway. Horm Res Paediatr. 2011;76(6):369–78. [DOI] [PubMed] [Google Scholar]
  • 8.Huber C, Munnich A, Cormier-Daire V. The 3 M syndrome. Best Pract Res Clin Endocrinol Metab. 2011;25(1):143–51. [DOI] [PubMed] [Google Scholar]
  • 9.Sasaki K, Okamoto N, Kosaki K, Yorifuji T, Shimokawa O, Mishima H, Yoshiura KI, Harada N. Maternal uniparental isodisomy and heterodisomy on chromosome 6 encompassing a CUL7 gene mutation causing 3 M syndrome. Clin Genet. 2011;80(5):478–83. [DOI] [PubMed] [Google Scholar]
  • 10.Al-Dosari MS, Al-Shammari M, Shaheen R, Faqeih E, Alghofely MA, Boukai A, Alkuraya FS. 3 M syndrome: an easily recognizable yet underdiagnosed cause of proportionate short stature. J Pediatr. 2012;161(1):139–e451. [DOI] [PubMed] [Google Scholar]
  • 11.Hanson D, Murray PG, Coulson T, Sud A, Omokanye A, Stratta E, Sakhinia F, Bonshek C, Wilson LC, Wakeling E, Temtamy SA, Aglan M, Rosser EM, Mansour S, Carcavilla A, Nampoothiri S, Khan WI, Banerjee I, Chandler KE, Black GC, Clayton PE. Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling. J Mol Endocrinol. 2012;49(3):267–75. [DOI] [PubMed] [Google Scholar]
  • 12.Demir K, Altıncık A, Böber E. Severe short stature due to 3-M syndrome with a novel OBSL1 gene mutation. J Pediatr Endocrinol Metab. 2013;26(1–2):147–50. [DOI] [PubMed] [Google Scholar]
  • 13.Meazza C, Lausch E, Pagani S, Bozzola E, Calcaterra V, Superti-Furga A, Silengo M, Bozzola M. 3-M syndrome associated with growth hormone deficiency: 18 year follow-up of a patient. Ital J Pediatr. 2013;39:21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Deeb A, Afandi O, Attia S, Fatih AE. 3-M syndrome: a novel CUL7 mutation associated with respiratory distress and a good response to GH therapy. Endocrinol Diabetes Metab Case Rep. 2015;2015:150012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lugli L, Bertucci E, Mazza V, Elmakky A, Ferrari F, Neuhaus C, Percesepe A. Pre- and post-natal growth in two sisters with 3-M syndrome. Eur J Med Genet. 2016;59(4):232–6. [DOI] [PubMed] [Google Scholar]
  • 16.Hu X, Li H, Gui B, Xu Y, Wang J, Li N, Su J, Zhang S, Song Y, Wang Y, Luo J, Fan X, Wang J, Chen S, Gong C, Shen Y. Prenatal and early diagnosis of Chinese 3-M syndrome patients with novel pathogenic variants. Clin Chim Acta. 2017;474:159–64. [DOI] [PubMed] [Google Scholar]
  • 17.Keskin M, Muratoğlu Şahin N, Kurnaz E, Bayramoğlu E, Savaş Erdeve Ş, Aycan Z, Çetinkaya S. A rare cause of short stature: 3 M syndrome in a patient with novel mutation in OBSL1 gene. J Clin Res Pediatr Endocrinol. 2017;9(1):91–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Liao L, Gan HW, Hwa V, Dattani M, Dauber A. Two siblings with a mutation in CCDC8 presenting with mild short stature: A case of 3-M syndrome. Horm Res Paediatr. 2017;88(5):364–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Takatani T, Shiohama T, Takatani R, Shimojo N. A novel CUL7 mutation in a Japanese patient with 3 M syndrome. Hum Genome Var. 2018;5:30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.HabibUllah H, Al-Baradie R, Bashir S. 3-M syndrome: A local case report. Am J Case Rep. 2019;20:36–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Shaikh S, Shettigar SKG, Kumar S, Kantharia S, Kurva J, Cherian S. Novel mutation in Cul7 gene in a family diagnosed with 3 M syndrome. J Genet. 2019;98:21. [PubMed] [Google Scholar]
  • 22.Simsek-Kiper PO, Taskiran E, Kosukcu C, Arslan UE, Cormier-Daire V, Gonc N, Ozon A, Alikasifoglu A, Kandemir N, Utine GE, Alanay Y, Alikasifoglu M, Boduroglu K. Further expanding the mutational spectrum and investigation of genotype-phenotype correlation in 3 M syndrome. Am J Med Genet A. 2019;179(7):1157–72. [DOI] [PubMed] [Google Scholar]
  • 23.Hu L, Wang X, Jin T, Han Y, Liu J, Jiang M, Yan S, Fu X, An B, Huang S. Identification of two CUL7 variants in two Chinese families with 3-M syndrome by whole-exome sequencing. J Clin Lab Anal. 2020;34(7):e23265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lee IK, Lim HH, Kim YM. The effect of combined growth hormone and a Gonadotropin-Releasing hormone agonist therapy on height in Korean 3-M syndrome siblings. Yonsei Med J. 2020;61(11):981–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Takizaki N, Tsurusaki Y, Katsumata K, Enomoto Y, Murakami H, Muroya K, Ishikawa H, Aida N, Nishimura G, Kurosawa K. Novel CUL7 biallelic mutations alter the skeletal phenotype of 3 M syndrome. Hum Genome Var. 2020;7:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Isik E, Arican D, Atik T, Ooi JE, Darcan S, Ozen S, Simsek Kiper PO, Utine E, Cogulu O, Ozkinay F. A rare cause of syndromic short stature: 3 M syndrome in three families. Am J Med Genet A. 2021;185(2):461–68. [DOI] [PubMed] [Google Scholar]
  • 27.Jacob P, Girisha KM. Three M syndrome 2 in two Indian patients. Am J Med Genet A. 2021;185(2):614–16. [DOI] [PubMed] [Google Scholar]
  • 28.Tüysüz B, Alp Ünkar Z, Turan H, Gezdirici A, Uludağ Alkaya D, Kasap B, Yeşil G, Vural M, Ercan O. Natural history of facial and skeletal features from neonatal period to adulthood in a 3 M syndrome cohort with biallelic CUL7 or OBSL1 variants. Eur J Med Genet. 2021;64(12):104346. [DOI] [PubMed] [Google Scholar]
  • 29.Khachnaoui-Zaafrane K, Ouertani I, Zanati A, Kandara H, Maazoul F, Mrad R. 3 M syndrome: A Tunisian seven-cases series. Eur J Med Genet. 2022;65(3):104448. [DOI] [PubMed] [Google Scholar]
  • 30.Akalın A, Şimşek-Kiper PÖ, Taşkıran E, Utine GE, Boduroğlu K. Typical Face, developmental Delay, and hearing loss in a patient with 3 M syndrome: the Co-Occurrence of two rare conditions. Mol Syndromol. 2023;13(6):537–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Karacan Küçükali G, Keskin M, Aycan Z, Savaş-Erdeve Ş, Çetinkaya S. 3 M syndrome: evaluating the clinical and laboratory features and the response of the growth hormone treatment: single center experience. Eur J Med Genet. 2023;66(10):104828. [DOI] [PubMed] [Google Scholar]
  • 32.Koprulu M, Shabbir RMK, Mumtaz S, Tolun A, Malik S. Expanding OBSL1 mutation phenotype: disproportionate short Stature, barrel Chest, thoracic Kyphoscoliosis, Hypogonadism, and hypospadias. Yale J Biol Med. 2023;96(3):367–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Xu N, Liu K, Yang Y, Li X, Zhong Y. Chinese patients with 3 M syndrome: clinical manifestations and two novel pathogenic variants. Front Genet. 2023;14:1164936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Akalın A, Özalkak Ş, Yıldırım R, et al. Clinical and molecular spectrum along with genotype-phenotype correlation of 25 patients diagnosed with 3 M syndrome: a study from Turkey. Eur J Pediatr. 2024;184(1):68. [DOI] [PubMed] [Google Scholar]
  • 35.Aldhoon-Hainerova I, Baranowski E, Kinning E, Dias RP. Gonadal failure in a male with 3-M syndrome. JCEM Case Rep. 2024;2(6):luae084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Alkhawaldeh A, Alsayed AR, Daghash R, Albaramiki J, Shibli D, Abudahab S, Hakooz N. The first study of 3-M syndrome in Jordan and literature review. Pharm Pract. 2024 Jan-Mar;22(1):2908.
  • 37.Luo MR, Dai SM, Li Y, Wang Q, Liu H, Gao P, Liu JY, Chen J, Zhao SJ, Yin GY. 3 M syndrome patient with a novel mutation: A case report. World J Clin Cases. 2024;12(8):1454–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Piao Y, Li R, Wang Y, Chen C, Sang Y. Novel OBSL1Variant in a Chinese patient with 3 M syndrome: the c.458dupG mutation May be a potential hotspot mutation in the Chinese population. J Clin Res Pediatr Endocrinol. 2024;16(4):501–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zaka A, Yousaf M, Shahzad S, Rao HZ, Foo JN, Siddiqi S. Structural and functional insights into a novel homozygous missense pathogenic variant in CUL7 identified in consanguineous Pakistani family. J Biomol Struct Dyn. 2024;42(10):5092–103. [DOI] [PubMed] [Google Scholar]
  • 40.Akilapa R, Irving M, Holder-Espinasse M. 3-M Syndrome. 2002 Mar 25 [updated 2025 Feb 27]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. [PubMed]
  • 41.Elsayed S, Elmakkawy GA, Abdelrazek IM, Fawzy DA, Kim J, Song Y, Omar OM, Abdalla EM. An update on 3 M syndrome: review of clinical and molecular aspects and report of additional families. Am J Med Genet A. 2025:e64068. [DOI] [PubMed]
  • 42.Yan J, Yan F, Li Z, Sinnott B, Cappell KM, Yu Y, Mo J, Duncan JA, Chen X, Cormier-Daire V, Whitehurst AW, Xiong Y. The 3 M complex maintains microtubule and genome integrity. Mol Cell. 2014;54(5):791–804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yang Q, Zhao J, Chen D, Wang Y. E3 ubiquitin ligases: styles, structures and functions. Mol Biomed. 2021;2(1):23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Dong Y, Chen Y, Ma G, Cao H. The role of E3 ubiquitin ligases in bone homeostasis and related diseases. Acta Pharm Sin B. 2023;13(10):3963–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.NCBI Gene Summary for. CUL7 Gene: https://www.ncbi.nlm.nih.gov/gene/9820.
  • 46.Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Litterman N, Ikeuchi Y, Gallardo G, O’Connell BC, Sowa ME, Gygi SP, Harper JW, Bonni A. An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates golgi morphology and dendrite patterning. PLoS Biol. 2011;9(5):e1001060. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1 (75.3KB, xlsx)

Data Availability Statement

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Italian Journal of Pediatrics are provided here courtesy of BMC

RESOURCES